Related Experiment Video
Updated: Feb 2, 2026

Construction of a High Resolution Microscope with Conventional and Holographic Optical Trapping Capabilities
Published on: April 22, 2013
Image-based Identification of Chemical Compounds Capable of Trapping FOXO in the Cell Nucleus
Susana Machado1, Catarina Raposo1, Bibiana I Ferreira1,2
1Centre for Biomedical Research (CBMR), University of Algarve, Faro, Portugal.
Abstract:
Forkhead box O (FOXO) factors are tumor suppressor proteins commonly inactivated in human tumors. Furthermore, genetic variation within the FOXO3a gene is consistently associated with human longevity. FOXO proteins are usually inactivated by posttranslational modifications leading to cytoplasmic mislocalization. Therefore, the pharmacological activation by promoting nuclear localization of FOXOs is considered an attractive therapeutic approach to treat cancer and age-related diseases. We developed a cell-based imaging assay to screen for chemical agents capable of inhibiting the nuclear export and in turn trapping proteins that contain a nuclear export sequence including FOXO factors in the nucleus. The fluorescent signal of untreated assay cells localizes predominantly to the cytoplasm. Upon treatment with the nuclear export inhibitors the fluorescent-tagged reporter proteins appear as speckles in the nucleus. In a personalized medicine context, drugs capable of reactivating FOXO factors might be of enormous clinical value in human tumors in which these proteins are inactivated. Here, we describe the procedures for monitoring nuclear export which is suitable for high-throughput screening of compound collections.
Insights
We developed a high-throughput screening assay to identify drugs that trap tumor suppressor proteins, Forkhead box O (FOXO) factors, in the nucleus. This approach could lead to new cancer and age-related disease treatments.
Area of Science:
- Molecular Biology
- Biochemistry
- Pharmacology
Background:
- Forkhead box O (FOXO) proteins are tumor suppressors frequently inactivated in human cancers.
- Genetic variations in FOXO3a are linked to human longevity.
- FOXO inactivation typically involves cytoplasmic mislocalization due to posttranslational modifications.
Purpose of the Study:
- To develop a cell-based imaging assay for screening chemical agents that inhibit nuclear export.
- To identify compounds that promote nuclear localization of FOXO proteins for therapeutic applications.
- To establish a high-throughput screening method for monitoring nuclear export.
Main Methods:
- Development of a cell-based imaging assay using fluorescent-tagged reporter proteins.
- Screening for chemical agents that inhibit nuclear export of proteins containing a nuclear export sequence.
- Monitoring changes in fluorescent signal localization (cytoplasmic vs. nuclear).
Main Results:
- The assay successfully distinguishes between cytoplasmic and nuclear localization of reporter proteins.
- Untreated cells show predominantly cytoplasmic localization of fluorescent signals.
- Inhibitors of nuclear export cause reporter proteins to accumulate in the nucleus.
Conclusions:
- Pharmacological activation of FOXO proteins by promoting nuclear localization is a promising therapeutic strategy.
- The developed assay is suitable for high-throughput screening of compound libraries.
- This approach holds potential for treating cancer and age-related diseases in a personalized medicine context.
Related Concept Videos
The Nucleus
Arrangement of DNA within Nucleus
The regulation of gene expression inside the nucleus is dependent on many factors, including the DNA structure. The...
Organic Compounds
Types of Chemical Bonds
Molecules and Compounds
Chemical Formulas
Social Traps

